Enovix Guides 2027 Revenue to $85M as Drone Orders Surge

Enovix Corporation (Nasdaq: ENVX) reported third-quarter 2026 revenue of $11.0 million on November 12, 2026, up 38% year over year, and guided fiscal 2027 revenue to $65 million to $85 million. The Fremont, California battery developer also retired $128 million face value of its 4.75% convertible senior notes due 2030 for roughly $81 million, a 36% discount, and cut about $8.5 million of annual cost through a 220-position restructuring.

Context — Why Enovix's 2027 Guidance Matters Now

The company's own numbers frame the scale of the reset. Enovix estimated fiscal 2026 revenue at $36.7 million to $37.7 million, built from $27.7 million of year-to-date revenue plus its fourth-quarter guidance of $9.0 million to $10.0 million. At the midpoint, the 2027 target is nearly double that 2026 estimate, and the company said almost half the midpoint already sits in backlog.

That backlog is drone-heavy. Enovix said its drone, defense and industrial pipeline grew 18% to approximately $216 million, from $183 million in the prior quarter, with drones accounting for $150 million of the total. The pipeline spans unmanned aerial vehicles, unmanned underwater vehicles, eVTOL aircraft and unmanned ground vehicles, served by both conventional graphite cells and higher-energy silicon-blended graphite cells.

Two orders converted that pipeline into 2027 revenue. A multinational dual-use drone systems provider placed an initial 100,000-battery purchase order for conventional cells. A U.S. drone manufacturer placed the first production order for the new MX1-B01 high-energy aerial drone cell after field trials, with initial deliveries scheduled for early 2027.

Steve Bakos, newly appointed Chief Revenue Officer and General Manager, said the MX1-B01 has been sampled by more than 30 aerial drone accounts. He added that customers need high-performance cells from a qualified, non-Chinese source and need them in volume next year.

Capacity is the constraint the company is addressing. Enovix said a $19 million expansion to double drone battery capacity at its military-qualified South Korean facility is underway and expected online in the second quarter of 2027, with further Korean investment planned to track drone and military demand.

Data — What the Q3 2026 Numbers Show

The margin line moved fastest. Non-GAAP gross margin reached 34.5% in the quarter, up 13.5 percentage points from 21.0% a year earlier. GAAP gross margin was 30.1%, against 17.5% in the third quarter of 2025. Enovix attributed the gain to a richer revenue mix, including smart eyewear, drone and defense revenue.

Operating performance improved more slowly. Non-GAAP operating loss was $29.2 million, roughly flat against $29.8 million a year earlier, while GAAP operating loss narrowed to $39.3 million from $47.0 million. Non-GAAP net loss per share was $0.15, versus $0.14 in the prior-year quarter. The company ended the quarter with $512.2 million in cash, cash equivalents, marketable securities and restricted cash, or $2.35 per outstanding share.

Metric	Q3 2025	Q3 2026
Revenue (non-GAAP)	$7.99M	$11.04M
Non-GAAP gross margin	21.0%	34.5%
Non-GAAP operating loss	$29.8M	$29.2M
Non-GAAP net loss/share	$0.14	$0.15

Capital structure work ran alongside the operating quarter. Enovix repurchased $6.2 million of common stock in the third quarter and another $15.5 million in October. The 2030 note retirement cut debt by $46.6 million more than the cash paid, leaving $232.0 million of those notes outstanding.

Fourth-quarter guidance implies a sequential revenue decline. Enovix guided Q4 2026 revenue to $9.0 million to $10.0 million, against $11.3 million in the fourth quarter of 2025, a drop of 12% to 20%. Guided non-GAAP operating loss is $28.0 million to $31.0 million, and capital expenditures are set at $5.0 million to $8.0 million.

Analysis — What It Means for Battery and Drone Supply Chains

The strategic pivot is the story behind the numbers. Enovix said its AI-1 cells passed internal cell-level qualification but did not meet its latest energy density target of more than 1,000 watt-hours per liter, because the qualification ran on the pre-AI-2 version of its process. The company decided not to proceed with system-level field testing on those pre-AI-2 units.

Silicon-anode development is now concentrated on smart eyewear, where Enovix said it has backlog. Year-to-date smart eyewear shipments reached approximately 19,000 units against a 50,000-pack backlog the company expects to complete in the first half of 2027, with AI-2 units still being sampled. Future energy-density gains, including AI-2, will go first to a group of 24 smart eyewear customers.

The limitation is that the 2027 revenue guide depends on converting pipeline, not contracted backlog, and on Korean capacity arriving on schedule in the second quarter of 2027. The company's own risk language flags that purchase orders or backlog may be modified, delayed, reduced or cancelled, and that customers may not place follow-on orders.

Positioning follows the same asymmetry. The warrant dividend gives holders of common stock and both note series a levered claim on a $3.00 strike, which aligns convertible holders with equity upside while the company retires debt below par. Anyone who sold borrowed shares ahead of the record date owes the warrants to the lender, a mechanical short squeeze risk the company explicitly described.

Outlook — What to Watch Next

Three dated catalysts anchor the next two quarters. The warrant record date is November 13, 2026, with distribution expected on or about November 18, 2026, and trading on Nasdaq under ENVXW. The warrants expire April 28, 2028, or earlier if the stock trades at or above $3.30 for 20 of any 30 consecutive trading days. Korean drone capacity is expected online in the second quarter of 2027.

The earnings call is scheduled for November 12, 2026, at 1:00 p.m. ET, with Executive Chairman T.J. Rodgers, Interim CEO Ryan Benton, Bakos and Chief Operating Officer Michael Vyvoda. Investors can submit questions during registration.

Levels to watch are the ones the report names: the $3.00 warrant strike and the $3.30 early-expiration trigger. The company did not disclose the terms of any further note repurchases beyond those already executed.

Frequently Asked Questions

What does Enovix's 2027 revenue guidance mean for retail investors?

The guide of $65 million to $85 million is a company expectation, not a booked result. Enovix said nearly half the midpoint is already in backlog, but backlog can be modified or cancelled. The midpoint is roughly double the $37.2 million midpoint of its own 2026 revenue estimate, so the target implies a steep conversion of drone and eyewear pipeline into shipments during 2027.

What happens to Enovix's 2030 convertible notes now?

Enovix retired $128.0 million face value of the 4.75% notes due 2030 for approximately $81.4 million, capturing a 36% discount and reducing debt by $46.6 million more than the cash paid. The remaining 2030 notes stand at $232.0 million. The gain appears in GAAP statements but not in non-GAAP results, which exclude certain one-time items.

Why did Enovix change its smartphone strategy?

The AI-1 cells passed internal cell-level qualification but missed the company's energy density target of more than 1,000 watt-hours per liter because testing used the pre-AI-2 process. Enovix decided against system-level field testing on those units and is now concentrating silicon-anode development on smart eyewear, where it holds a 50,000-pack backlog.

Bottom Line

Enovix is trading smartphone optionality for drone and eyewear revenue it can date, and the 2027 guide is the first test of whether that bet converts.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.